Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Finished Goods (2023 - 2025)

Historic Finished Goods for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $48141.0.

  • Onconetix's Finished Goods rose 10126.68% to $48141.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $48141.0, marking a year-over-year increase of 10126.68%. This contributed to the annual value of $6633.0 for FY2024, which is 7791.87% down from last year.
  • Onconetix's Finished Goods amounted to $48141.0 in Q3 2025, which was up 10126.68% from $49361.0 recorded in Q2 2025.
  • Onconetix's Finished Goods' 5-year high stood at $68301.0 during Q2 2024, with a 5-year trough of $4966.0 in Q1 2024.
  • For the 3-year period, Onconetix's Finished Goods averaged around $36980.8, with its median value being $39090.0 (2023).
  • Per our database at Business Quant, Onconetix's Finished Goods crashed by 7791.87% in 2024 and then surged by 119855.01% in 2025.
  • Quarter analysis of 3 years shows Onconetix's Finished Goods stood at $30039.0 in 2023, then crashed by 77.92% to $6633.0 in 2024, then soared by 625.78% to $48141.0 in 2025.
  • Its Finished Goods stands at $48141.0 for Q3 2025, versus $49361.0 for Q2 2025 and $64486.0 for Q1 2025.